418 related articles for article (PubMed ID: 24980054)
21. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.
Ronga L; Del Favero M; Cohen A; Soum C; Le Pape P; Savrimoutou S; Pinaud N; Mullié C; Daulouede S; Vincendeau P; Farvacques N; Agnamey P; Pagniez F; Hutter S; Azas N; Sonnet P; Guillon J
Eur J Med Chem; 2014 Jun; 81():378-93. PubMed ID: 24858543
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiprotozoal activity of original porphyrin precursors and derivatives.
Abada Z; Cojean S; Pomel S; Ferrié L; Akagah B; Lormier AT; Loiseau PM; Figadère B
Eur J Med Chem; 2013 Sep; 67():158-65. PubMed ID: 23851117
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of novel guttiferone A derivatives: in-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovani.
Fromentin Y; Gaboriaud-Kolar N; Lenta BN; Wansi JD; Buisson D; Mouray E; Grellier P; Loiseau PM; Lallemand MC; Michel S
Eur J Med Chem; 2013 Jul; 65():284-94. PubMed ID: 23727538
[TBL] [Abstract][Full Text] [Related]
25. Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.
Bharate SB; Bharate JB; Khan SI; Tekwani BL; Jacob MR; Mudududdla R; Yadav RR; Singh B; Sharma PR; Maity S; Singh B; Khan IA; Vishwakarma RA
Eur J Med Chem; 2013 May; 63():435-43. PubMed ID: 23517732
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological activities of cilantro's aliphatic aldehydes against Leishmania donovani.
Donega MA; Mello SC; Moraes RM; Jain SK; Tekwani BL; Cantrell CL
Planta Med; 2014 Dec; 80(18):1706-11. PubMed ID: 25340465
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
Peyron C; Benhida R; Bories C; Loiseau PM
Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
[TBL] [Abstract][Full Text] [Related]
29. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies.
Tasdemir D; Kaiser M; Brun R; Yardley V; Schmidt TJ; Tosun F; Rüedi P
Antimicrob Agents Chemother; 2006 Apr; 50(4):1352-64. PubMed ID: 16569852
[TBL] [Abstract][Full Text] [Related]
30. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
Jagu E; Pomel S; Diez-Martinez A; Ramiandrasoa F; Krauth-Siegel RL; Pethe S; Blonski C; Labruère R; Loiseau PM
Bioorg Med Chem; 2017 Jan; 25(1):84-90. PubMed ID: 27793448
[TBL] [Abstract][Full Text] [Related]
32. Simple and efficient synthesis of 5'-aryl-5'-deoxyguanosine analogs by azide-alkyne click reaction and their antileishmanial activities.
Daligaux P; Pomel S; Leblanc K; Loiseau PM; Cavé C
Mol Divers; 2016 May; 20(2):507-19. PubMed ID: 26754628
[TBL] [Abstract][Full Text] [Related]
33. Antiprotozoal activity of synthetic amino substituted 1-methyl-1 H-alpha-carbolines.
Verbeeck S; Yadav AK; Maes BU; Augustyns K; Van Der Veken P; Cos P; Maes L; Pieters L
Pharmazie; 2014 Feb; 69(2):83-5. PubMed ID: 24640594
[TBL] [Abstract][Full Text] [Related]
34. Antiprotozoal compounds from Psorothamnus polydenius.
Salem MM; Werbovetz KA
J Nat Prod; 2005 Jan; 68(1):108-11. PubMed ID: 15679330
[TBL] [Abstract][Full Text] [Related]
35. Trypanocidal and antileishmanial dihydrochelerythrine derivatives from Garcinia lucida.
Fotie J; Bohle DS; Olivier M; Adelaida Gomez M; Nzimiro S
J Nat Prod; 2007 Oct; 70(10):1650-3. PubMed ID: 17880175
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D
Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747
[TBL] [Abstract][Full Text] [Related]
37. Preparation and antiprotozoal evaluation of promising β-carboline alkaloids.
Gellis A; Dumètre A; Lanzada G; Hutter S; Ollivier E; Vanelle P; Azas N
Biomed Pharmacother; 2012 Jul; 66(5):339-47. PubMed ID: 22397756
[TBL] [Abstract][Full Text] [Related]
38. 8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases.
Fersing C; Boudot C; Pedron J; Hutter S; Primas N; Castera-Ducros C; Bourgeade-Delmas S; Sournia-Saquet A; Moreau A; Cohen A; Stigliani JL; Pratviel G; Crozet MD; Wyllie S; Fairlamb A; Valentin A; Rathelot P; Azas N; Courtioux B; Verhaeghe P; Vanelle P
Eur J Med Chem; 2018 Sep; 157():115-126. PubMed ID: 30092366
[TBL] [Abstract][Full Text] [Related]
39. Novel β-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity.
Ramu D; Garg S; Ayana R; Keerthana AK; Sharma V; Saini CP; Sen S; Pati S; Singh S
Biochem Pharmacol; 2017 Apr; 129():26-42. PubMed ID: 28017772
[TBL] [Abstract][Full Text] [Related]
40. Identification of a diverse indole-2-carboxamides as a potent antileishmanial chemotypes.
Pandey S; Chauhan SS; Shivahare R; Sharma A; Jaiswal S; Gupta S; Lal J; Chauhan PM
Eur J Med Chem; 2016 Mar; 110():237-45. PubMed ID: 26840364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
